These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
210 related items for PubMed ID: 15575856
1. Voriconazole-induced retinoid-like photosensitivity in children. Rubenstein M, Levy ML, Metry D. Pediatr Dermatol; 2004; 21(6):675-8. PubMed ID: 15575856 [Abstract] [Full Text] [Related]
5. Idiosyncratic nature of voriconazole photosensitivity in children undergoing cancer therapy. Hansford JR, Cole C, Blyth CC, Gottardo NG. J Antimicrob Chemother; 2012 Jul 01; 67(7):1807-9. PubMed ID: 22454488 [No Abstract] [Full Text] [Related]
6. Voriconazole: a new triazole antifungal agent. Johnson LB, Kauffman CA. Clin Infect Dis; 2003 Mar 01; 36(5):630-7. PubMed ID: 12594645 [Abstract] [Full Text] [Related]
7. Voriconazole inhibition of vitamin A metabolism: are adverse events increased in cystic fibrosis patients? Cheng MP, Paquette K, Lands LC, Ovetchkine P, Théoret Y, Quach C. Pediatr Pulmonol; 2010 Jul 01; 45(7):661-6. PubMed ID: 20575095 [Abstract] [Full Text] [Related]
8. [Porphyria cutanea tarda revealed by voriconazole]. Hickman G, Duval A, Picard C, Petit A. Ann Dermatol Venereol; 2010 Jan 01; 137(1):36-9. PubMed ID: 20110066 [Abstract] [Full Text] [Related]
11. Voriconazole in newborns. Kohli V, Taneja V, Sachdev P, Joshi R. Indian Pediatr; 2008 Mar 01; 45(3):236-8. PubMed ID: 18367773 [Abstract] [Full Text] [Related]
12. Muco-cutaneous retinoid-effects and facial erythema related to the novel triazole antifungal agent voriconazole. Denning DW, Griffiths CE. Clin Exp Dermatol; 2001 Nov 01; 26(8):648-53. PubMed ID: 11722447 [Abstract] [Full Text] [Related]
13. New treatment for invasive fungal sinusitis: three cases of chronic invasive fungal sinusitis treated with surgery and voriconazole. Nakaya K, Oshima T, Kudo T, Aoyagi I, Katori Y, Ota J, Hidaka H, Oda K, Kobayashi T. Auris Nasus Larynx; 2010 Apr 01; 37(2):244-9. PubMed ID: 19553042 [Abstract] [Full Text] [Related]
14. Photosensitivity in immunocompromised patients receiving long-term therapy with oral voriconazole. Frick MA, Soler-Palacín P, Martín Nalda A, Guarner ME, Nadal CF. Pediatr Infect Dis J; 2010 May 01; 29(5):480-1. PubMed ID: 20431387 [No Abstract] [Full Text] [Related]
15. Severe phototoxicity associated with long-term voriconazole treatment. Vöhringer S, Schrum J, Ott H, Höger PH. J Dtsch Dermatol Ges; 2011 Apr 01; 9(4):274-6. PubMed ID: 21050383 [Abstract] [Full Text] [Related]
16. Pseudoporphyria associated with voriconazole. Kwong WT, Hsu S. J Drugs Dermatol; 2007 Oct 01; 6(10):1042-4. PubMed ID: 17966183 [Abstract] [Full Text] [Related]
18. Lupus erythematosus-like lesions by voriconazole in an infant with chronic granulomatous disease. Gomez-Moyano E, Vera-Casaño A, Moreno-Perez D, Sanz-Trelles A, Crespo-Erchiga V. Pediatr Dermatol; 2010 Oct 01; 27(1):105-6. PubMed ID: 20199430 [Abstract] [Full Text] [Related]
19. Adverse reactions to voriconazole. Boyd AE, Modi S, Howard SJ, Moore CB, Keevil BG, Denning DW. Clin Infect Dis; 2004 Oct 15; 39(8):1241-4. PubMed ID: 15486850 [Abstract] [Full Text] [Related]
20. Voriconazole for invasive bone aspergillosis: a worldwide experience of 20 cases. Mouas H, Lutsar I, Dupont B, Fain O, Herbrecht R, Lescure FX, Lortholary O, Voriconazole/Bone Invasive Aspergillosis Study Group. Clin Infect Dis; 2005 Apr 15; 40(8):1141-7. PubMed ID: 15791514 [Abstract] [Full Text] [Related] Page: [Next] [New Search]